can tirzepatide affect period Weekly Weight Loss on Tirzepatide: What to Expect Tirzepatide & Menstrual Changes: What

brand-name medications Compounded semaglutide is not approved by the FDA for weight loss or diabetes

USA 107 , 32813282 (2010)

At the highest Zepbound dose of 15 mg weekly, results showed: Average weight loss: 22.5% of body weight Breaking down the success rates: 96% lost at least 5% of body weight 89% lost at least 10% of body weight 78% lost at least 15% of body weight 63% lost at least 20% of body weight For someone weighing 220 pounds, losing 22.5% means dropping about 50 pounds to reach 170 pounds

Drugs under the same class were regarded as one treatment node and pooled effect sizes were estimated regardless of drug dose

Clinical trials show that patients on semaglutide naturally reduce calorie intake by 3040% without conscious restriction, largely because they feel satisfied after smaller meals and experience fewer hunger urges between eating windows

Lilly is also running two other trials with eloralintide plus tirzepatide, including another mid-stage study in obese and overweight type 2 diabetes patients, with an initial completion date in June 2026, and a Phase I trial in nondiabetic individuals, scheduled to complete in October 2025